| Serial Number | 79244477 |
| Word Mark | CURADIGM |
| Filing Date | Wednesday, August 1, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 9, 2019 |
| Registration Number | 5796583 |
| Registration Date | Tuesday, July 9, 2019 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, April 23, 2019 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Products for medical use especially for metabolic pathways, namely, enzyme substrates and enzyme inhibitors; products for medical use especially for the diagnosis and treatment of tumors, namely, diagnostic preparation for medical purposes for the diagnosis of tumors and therapeutic pharmaceutical preparations for medical purposes for the treatment of tumors and rare hepatic diseases; preparations for medical use especially for modifying the bioavailability of therapeutic agents, namely, lipidic and polymeric formulation for drug delivery in the nature of drug delivery agents in the form of nanoparticles, nanovesicles, particles, vesicles, dissolvable films, coatings for tablets and hydrogels that facilitate the delivery of pharmaceutical preparations; preparations for medical use especially for modifying liver functions, namely, pharmaceutical preparations for the treatment of liver diseases and disorders and pharmaceutical preparations to alter hepatic metabolization pathways; preparations for medical use for modifying the functions of the reticuloendothelial system, namely, pharmaceutical preparations for the treatment of reticuloendothelial system diseases and disorders and pharmaceutical preparations to alter reticuloendothelial system endocytosis pathways; preparations made with nanomaterials for the delivery of therapeutic agents, namely, drug delivery agents in the form of enterally, parenterally in the nature of intravenous, or topically administered nanomaterials that facilitate the delivery of pharmaceutical preparations; chemical reagents for medical use; bacteriological preparations for medical use; biological preparations for medical use for the treatment of cancer, central nervous system disorders, cardiological, immunological, gastrointestinal, metabolic and infection diseases; enzymes for medical use; enzyme preparations for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; diagnostic products for medical use, namely, diagnostic preparations for medical purposes; drugs for medical use, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; medicines for human medicine, namely, medical preparations for the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infectious diseases; tonics medicines, namely, medical herbal preparations; antibiotics; antiseptics; chemico-pharmaceutical products for the treatment of the treatment of cancer, central nervous system disorder, cardiological, immunological, gastrointestinal, metabolic and infection diseases; pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; dietetic substances for medical use, namely, dietetic foods adapted for medical purposes; remedies for human medicine, namely, natural remedy preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalances, and sleep disorders |
| Goods and Services | Surgical and medical apparatus and instruments especially for the diagnosis and treatment of tumors; Surgical and medical apparatus and instruments especially for monitoring and modifying metabolic functions; Apparatus for modifying the functions of the reticuloendothelial system, namely, medical apparatus and instruments for use in endovascular and cardiovascular procedures; Apparatus for modulating liver functions, namely, medical apparatus and instruments for use in measuring, quantifying and assessing liver health and oxygenation and perfusion apparatus in the nature of perfusion pumps for liver transplantation; Apparatus for the delivery of therapeutic or diagnostic agents, namely, medical apparatus and units for dosage, measuring and monitoring, in the nature of drug delivery devices and systems, and organ oxygenation and perfusion apparatus in the nature of perfusion pumps; Apparatus for modulating hepatic blood flow, namely, organ perfusion apparatus in the nature of perfusion pumps; Testing apparatus for medical use in the nature of medical diagnostic apparatus for testing cancer calls, DNA, organ oxygenation and blood sugar levels; Diagnostic apparatus for medical use for testing cancer calls, DNA, organ oxygenation and blood sugar levels |
| Goods and Services | Scientific and technological services, namely, research and design especially in the field of nanomedicine, in the nature of nanotechnology applied to medicine; Biological research services; Bacteriological research services; Evaluations, estimates and research in scientific and technological fields provided by engineers and researchers, namely, conducting early evaluations in the field of new pharmaceuticals; Design and development of new products for third parties in the field of pharmaceutical preparations and diagnostic devices design; Technical research in the field of pharmaceutical project studies; Industrial analysis and research services, namely, biomedical research services; Chemical analysis; Chemical research; Chemistry services, namely, chemistry consultation; Surveying, namely, engineering work; Research and development of new products for others; Technical research in the field of pharmaceutical studies; Biological research, namely, radiobiology research, biological, pharmacokinetic, pharmacodynamic and immunological evaluation and toxicological evaluation; Medical research, namely, research in nanoscience and nanotechnology, especially applied to medicine |
| Goods and Services | Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 7, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 7, 2018 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 7, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 7, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CURADIGM |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Party Name | NANOBIOTIX |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Party Name | NANOBIOTIX |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Party Name | NANOBIOTIX |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Thursday, February 27, 2020 | CHANGE OF OWNER RECEIVED FROM IB |
| Friday, November 15, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, October 29, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, October 29, 2019 | FINAL DISPOSITION PROCESSED |
| Wednesday, October 9, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, July 9, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Friday, May 3, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, April 23, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 17, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 17, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 3, 2019 | NOTICE OF PUBLICATION |
| Friday, March 15, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 15, 2019 | EXAMINERS AMENDMENT MAILED |
| Thursday, March 14, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 14, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, March 8, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 7, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 7, 2019 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, March 4, 2019 | FINAL REFUSAL MAILED |
| Friday, March 1, 2019 | FINAL REFUSAL WRITTEN |
| Friday, February 8, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 8, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 7, 2019 | ASSIGNED TO LIE |
| Sunday, February 3, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 21, 2018 | REFUSAL PROCESSED BY IB |
| Tuesday, December 4, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, December 4, 2018 | REFUSAL PROCESSED BY MPU |
| Monday, November 19, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, November 18, 2018 | NON-FINAL ACTION WRITTEN |
| Sunday, November 18, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, November 13, 2018 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, November 7, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, November 1, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |